前列腺癌的聚焦消融
Focal Ablation of Prostate Cancer.
作者信息
Lepor Herbert, Gold Samuel, Wysock James
机构信息
Department of Urology, NYU Langone Medical Center New York, NY.
出版信息
Rev Urol. 2018;20(4):145-157. doi: 10.3909/riu0809.
Abstract
The challenge to the urology community is to reduce the risks of screening and treatment by reducing the number of men undergoing unnecessary biopsy and whole-gland curative treatment of low-risk disease. There is compelling evidence that focal ablation of prostate cancer is truly minimally invasive and offers major functional advantages over whole-gland treatment.
摘要
泌尿学界面临的挑战是，通过减少接受不必要活检和对低风险疾病进行全腺根治性治疗的男性数量，来降低筛查和治疗的风险。有令人信服的证据表明，前列腺癌的局部消融是真正的微创治疗，与全腺治疗相比具有主要的功能优势。
相似文献
1
Focal Ablation of Prostate Cancer.
Rev Urol. 2018;20(4):145-157. doi: 10.3909/riu0809.
2
New treatments for localized prostate cancer.
Urology. 2008 Dec;72(6 Suppl):S36-43. doi: 10.1016/j.urology.2008.08.506.
3
Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years.
Curr Opin Urol. 2021 Jan;31(1):49-57. doi: 10.1097/MOU.0000000000000838.
4
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Eur Urol. 2017 Jan;71(1):17-34. doi: 10.1016/j.eururo.2016.08.044. Epub 2016 Aug 29.
5
Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Eur Urol Oncol. 2020 Jun;3(3):283-290. doi: 10.1016/j.euo.2019.04.008. Epub 2019 May 16.
6
"Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.
Gland Surg. 2018 Apr;7(2):166-187. doi: 10.21037/gs.2018.03.06.
7
An update on focal therapy for prostate cancer.
Nat Rev Urol. 2016 Nov;13(11):641-653. doi: 10.1038/nrurol.2016.177. Epub 2016 Sep 27.
8
Targeting the cancer lesion, not the whole prostate.
Transl Androl Urol. 2020 Jun;9(3):1518-1525. doi: 10.21037/tau.2019.09.12.
9
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
J Urol. 2016 Sep;196(3):883-90. doi: 10.1016/j.juro.2016.02.2986. Epub 2016 Apr 23.
10
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
BJU Int. 2020 Mar;125(3):369-378. doi: 10.1111/bju.14951. Epub 2019 Dec 5.
引用本文的文献
1
A Prospective Pilot Study Investigating Performance of 18F-Fluciclovine PET Imaging for Detection of Prostate Cancer 2 Years Following Primary Partial Gland Cryoablation.
Nucl Med Mol Imaging. 2022 Aug;56(4):196-201. doi: 10.1007/s13139-022-00755-5. Epub 2022 Jun 21.
2
Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Int J Nanomedicine. 2021 Apr 12;16:2775-2787. doi: 10.2147/IJN.S301552. eCollection 2021.
3
MRI guided procedure planning and 3D simulation for partial gland cryoablation of the prostate: a pilot study.
3D Print Med. 2020 Nov 3;6(1):33. doi: 10.1186/s41205-020-00085-2.
4
Focal therapy, time to join the multi-disciplinary team discussion?
Transl Androl Urol. 2020 Jun;9(3):1526-1534. doi: 10.21037/tau.2019.09.30.
5
Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone.
Prostate Cancer Prostatic Dis. 2021 Mar;24(1):114-119. doi: 10.1038/s41391-020-0244-0. Epub 2020 Jul 7.
6
Prostate Cancer Screening and Management in Solid Organ Transplant Candidates and Recipients.
Rev Urol. 2019;21(2-3):85-92.
本文引用的文献
1
Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Eur Urol Oncol. 2018 Jun;1(2):129-133. doi: 10.1016/j.euo.2018.03.011. Epub 2018 May 15.
2
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.
J Urol. 2018 Oct;200(4):786-793. doi: 10.1016/j.juro.2018.05.121. Epub 2018 Jun 2.
3
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
4
Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data.
J Endourol. 2018 Sep 12;32(9):797-804. doi: 10.1089/end.2018.0130. Epub 2018 Jun 27.
5
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18.
6
Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.
Eur Urol. 2018 Jul;74(1):84-91. doi: 10.1016/j.eururo.2018.01.001. Epub 2018 Jan 17.
7
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.
J Urol. 2018 Jun;199(6):1488-1493. doi: 10.1016/j.juro.2017.12.058. Epub 2018 Jan 4.
8
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
J Urol. 2018 Apr;199(4):983-989. doi: 10.1016/j.juro.2017.10.033. Epub 2017 Oct 26.
9
The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.
Urology. 2018 Feb;112:121-125. doi: 10.1016/j.urology.2017.10.014. Epub 2017 Oct 20.
10
Focal irreversible electroporation as primary treatment for localized prostate cancer.
BJU Int. 2018 May;121(5):716-724. doi: 10.1111/bju.13983. Epub 2017 Sep 4.
Zotero 插件